This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
A national public health organization is calling for Health Secretary Robert F. Kennedy Jr. to resign the federal post he assumed just weeks ago, citing “implicit and explicit bias and complete disregard for science.” Georges Benjamin, executive director of the American Public Health Association, said in a statement on Wednesday that concerns raised during Kennedy’s confirmation hearing last month have been realized, followed by massive reductions in staff at key health agen
It's time for Drug Channels annual update of vertical integration among insurers, PBMs, specialty pharmacies, and healthcare services within U.S. drug channels. As you can see below, we have revised, renovated, and refurbished our infamous illustration of the major vertical business relationships among the largest companies. Proponents of these vertical integration arrangements argue that they create opportunities to mine healthcare costs.
“This year is going to be the year AI agents are going to get deployed,” NVIDIA CEO Jensen Huang declared at this year’s Consumer Electronics Show. But what are AI agents, and how do they apply to health care? Several health tech companies have jumped in on agents. One of the early entrants, Hippocratic AI, has a lineup of AI “nurses” that health systems can deploy for specific workflows, such as discussing cervical cancer screening or checking in on a chronic
"Unlocking New Hope for Neurological Disorders As we continue to push the boundaries of medical innovation, I'm excited to share with you a game-changing development in the fight against neurological disorders. At the forefront of this revolution is AI-based drug repurposing. By leveraging cutting-edge technology, researchers are re-examining existing medications to identify new uses for treating conditions such as Alzheimer's, Parkinson's, and multiple sclerosis.
Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.
Two decades ago, when I first began practicing emergency medicine, patient documentation was a manual process. I would write on carbon-copy forms that were later stored in the belly of the hospital, in archives, as patient files. To get a lab test, an X-ray, or a medication for a patient, I had to jot down instructions on a piece of paper, track down the right nurse, and verbally convey what orders I had put in.
Biocon Biologics (BBL), a subsidiary of Biocon (BSE code: 532523, NSE: BIOCON), has announced that the U.S. Food and Drug Administration (FDA) has approved JOBEVNE (bevacizumab-nwgd), a biosimilar to Avastin (bevacizumab), for intravenous use. JOBEVNE is a recombinant humanised monoclonal antibody used in the treatment of multiple types of cancer. JOBEVNE functions as a vascular endothelial growth factor (VEGF) inhibitor.
Biocon Biologics (BBL), a subsidiary of Biocon (BSE code: 532523, NSE: BIOCON), has announced that the U.S. Food and Drug Administration (FDA) has approved JOBEVNE (bevacizumab-nwgd), a biosimilar to Avastin (bevacizumab), for intravenous use. JOBEVNE is a recombinant humanised monoclonal antibody used in the treatment of multiple types of cancer. JOBEVNE functions as a vascular endothelial growth factor (VEGF) inhibitor.
Amid the hard-to-follow cutbacks at the U.S. Food and Drug Administration, a little-known but important office was eliminated — and the implications will be felt not only by drugmakers, but consumers. The Division of Policy Development in the Office of Generic Drug Policy, which was created more than a decade ago, was responsible for a host of activities that were central to ensuring generic drugs were approved properly for the American market.
Patient-Centric Approaches to Maintaining Brand Value As the pharmaceutical industry continues to evolve, one thing remains clear: patients are at the forefront of every decision. At DrugPatentWatch, we've seen firsthand how patient-centric approaches can make all the difference in maintaining brand value. In our latest blog post, we explore the importance of putting patients first in brand strategy.
Y ou’re reading the web edition of STAT’s AI Prognosis newsletter, our subscriber-exclusive guide to artificial intelligence in health care and medicine. Sign up to get it delivered in your inbox every Wednesday. As a STAT+ subscriber, you have access to our STAT trackers — including our Breakthrough Device Tracker, Obesity Drug Tracker, and CRISPR Trackr (hehe, get it?
The Federation of Pharma Entrepreneurs (FOPE), in collaboration with PharmaState Academy, conducted the 18th session of its ongoing PULSE (Pharma Upgradation & Learning Series for Excellence) initiative. The session focused on the manufacture of sterile drug products in line with the Revised Schedule M, bringing together key stakeholders and experts from across the pharmaceutical manufacturing ecosystem.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Good morning. Yesterday, there was a turkey (or, as one reporter guessed, a turkey vulture?) on the ledge outside STAT’s office windows all day. We’re on the third floor! Scroll all the way down for a picture of our new friend, and send in suggestions for a name. A harbinger of more growth in measles cases Cases in the West Texas measles outbreak are now appearing in urban areas, a formula for greater growth, Katherine Wells, director of public health for the city of Lubbock, told
Just spent the day diving into the world of biosimilars and regulatory considerations. Key takeaways from the article on DrugPatentWatch: Biosimilar extrapolation of indications is a complex process that requires a deep understanding of the regulatory landscape. The FDA has established a framework for evaluating biosimilarity, but there is still a lack of clarity around extrapolation.
You’re reading The MAHA Diagnosis , a STAT series that examines the major elements of the Make America Healthy Again movement led by Robert F. Kennedy Jr. The U.S. measles outbreak is getting worse. The Department of Health and Human Services is cutting 10,000 jobs and sparking fears about the future of the country’s ability to monitor environmental contaminants and prevent disease.
The cancer biotech company Infinitopes has gained approval by the UK Medicines and Healthcare products Regulatory Agency (MHRA) to evaluate its ITOP1 vaccine targeting oesophageal cancer. This marks the first ever trial to administer a cancer vaccine in a neoadjuvant setting while the primary tumour remains. With Clinical Trial Application (CTA) approval, the upcoming phase […] The post Infinitopes launches first-in-human trial of vaccine targeting oesophageal cancer appeared first on Phar
Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.
Jazz Pharmaceuticals said on Tuesday that it had agreed to a settlement of $145 million to resolve a series of antitrust lawsuits related to its narcolepsy drug, Xyrem. Xyrem, a medication approved in the U.S., is used for the treatment of excessive daytime sleepiness and sudden loss of muscle control in patients suffering from narcolepsy, a chronic neurological disorder.
A new Digital Architecture framework is anticipated to help transform the process of manufacturing pharmaceuticals, by helping companies to progress towards autonomous manufacturing.The digitalisation-focused initiative is a collaborationbetween the Centre for Process Innovation (CPI) and industry partners including AstraZeneca and GSK. This framework delivers a clear strategy for companies to incorporate digital technologies, enable real-time release for drug manufacturing and address key chall
“There will be a ChatGPT moment for biotechnology,” a bipartisan commission wrote in the new report, which calls for the U.S. to invest at least $15 billion into the sector over the next five years.
Imagine launching a breakthrough therapybut the right people never see it. In a world dominated by digital conversations, failing to master pharma digital marketing is no longer an optionits a risk to market performance. Pharma marketers today must navigate not only consumer expectations but also a tightly regulated environment. The stakes are high, but so are the opportunities.
Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.
At NABP, one of the ways in which we support patient safety is by offering examinations that assess a pharmacists competency to practice. The Multistate Pharmacy Jurisprudence Examination (MPJE ) is specifically designed to evaluate candidates understanding and application of federal and state-specific laws and regulations. The exam measures both candidates’ knowledge of these laws and their ability to apply that knowledge to their pharmacy practice.
General practice staff who are members of the NHS pension and affected by the McCloud case face losing out financially because of delays in receiving key paperwork, experts have said. Just under 400,000 members of the pension scheme all of whom have already retired were due to receive remediable service statements (RSS), that provide […] The post McCloud NHS pensioners face financial disadvantage due to admin delays appeared first on The Pharmacist.
Logistics4Pharma, a GDP-certified pharmaceutical logistics provider based in Frankfurt, has expanded its service offerings by integrating a comprehensive transit document service with customs-secured transportation into its existing portfolio. This addition builds on the companys existing temporary storage services under customs supervision. The extended services are available near Frankfurt International Airport and aim to streamline supply chain operations by offering a consolidated customs so
Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.
"Market Domination Through Cost Optimization: A Game-Changer for Generic Drug Manufacturers As the pharmaceutical industry continues to evolve, generic drug manufacturers are facing increasing pressure to reduce production costs while maintaining quality and regulatory compliance. At DrugPatentWatch, we've identified key strategies to help generic drug manufacturers optimize their production costs and gain a competitive edge in the market.
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
At the recently held American Academy of Neurology (AAN) 2025 annual meeting, Axsome Therapeutics presented promising data for AXS-05 (bupropion + dextromethorphan) in treating agitation associated with Alzheimers disease (AD). With a novel, non-antipsychotic mechanism and a favorable safety profile, AXS-05 addresses a critical unmet need in managing distressing behavioral symptoms, potentially reshaping the current treatment paradigms in a space largely reliant on off-label antipsychotic use, s
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
364 
Let's personalize your content